John K Bell Net Worth & Insider Trades

John K Bell - Director, Delmar Pharmaceuticals, Inc

As of June 30, 2020

What is John K Bell's Net Worth?

The current estimated net worth of Delmar Pharmaceuticals, Inc's Director, John K Bell, is estimated to be about $2.62K . John K Bell owns about 44,701 units of Delmar Pharmaceuticals, Inc common stock. In the last 4 years at Delmar Pharmaceuticals, Inc, John K Bell has sold an estimated value of $0 worth.

What is John K Bell's Past Insider Trading?

John K Bell's largest purchase order was 35,000 units , worth over $23.74K on September 16, 2019. In total, John K Bell has made about 26 transactions over 4 years of their time at Delmar Pharmaceuticals, Inc. John K Bell usually trades in July, with the busiest year in 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is John K Bell's' Mailing Address?

  • Mailing address is 38 Fallbrook Lane RR 33 Cambridge A6 N3H 4R8 Ontario, Canada

What are Delmar Pharmaceuticals, Inc's Past Insider Trades?

Delmar Pharmaceuticals, Inc's most recent insider trade came on September 16, 2019 by John K Bell who bought 35,000 units worth $23.74K . In the last 6 years, insiders at Delmar Pharmaceuticals, Inc have sold an estimated value of $104K and bought an estimated value of $1.17M worth of shares. Insider trading is most common in July, with the busiest year in 2017. The most active traders at the company are John K Bell, Director,  Jeffrey Bacha, Director,  and Dennis M Brown, Chief Scientific Officer .

DelMar Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...